Begacestat
- Generic Name
- Begacestat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H8ClF6NO3S2
- CAS Number
- 769169-27-9
- Unique Ingredient Identifier
- 3666C56BBU
- Background
Begacestat has been used in trials studying the treatment and basic science of Alzheimer Disease.
- Associated Conditions
- -
- Associated Therapies
- -
Study Evaluating The Coadministration of Begacestat And Donepezil
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-08-17
- Last Posted Date
- 2011-04-04
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Target Recruit Count
- 47
- Registration Number
- NCT00959881
- Locations
- 🇺🇸
Pfizer Investigational Site, Overland Park, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath